Managing Director, Intellectual Property Strategies, Toronto
Bern joined the Intellectual Property (IP) Strategies team at OMERS in 2016. Since coming on-board, Bern has been focused on originating, evaluating, and negotiating pharmaceutical royalty transactions.
Before joining OMERS, Bern worked for more than ten years at DRI Capital, a life sciences private equity firm focused on the acquisition of pharmaceutical royalties. Bern also worked previously at Novo Nordisk (Canada), where he was responsible for sales and marketing analytics for the biopharmaceuticals portfolio.
Bern received a PhD in neurophysiology and molecular biology from Queen’s University in Kingston, where he held an NSERC Scholarship. He received an MBA from the University of Toronto, where he held an Ontario Graduate Scholarship.